Glycogen Storage Disease Type Viii

Overview of Glycogen Storage Disease Type Viii

Most recent studies have shown that Glycogen Storage Disease Type Viii shares some biological mechanisms with carcinoma, diabetes-mellitus, diabetes-mellitus-insulin-dependent, fanconi-syndrome, glycogen-storage-disease, glycogen-storage-disease-type-i, glycogen-storage-disease-type-ii, glycogen-storage-disease-type-iii, glycogen-storage-disease-type-iv, glycogen-storage-disease-type-v, glycogen-storage-disease-type-vii, hepatomegaly, hyperuricemia, hypoglycemia, liver-carcinoma, liver-cirrhosis, liver-diseases, liver-neoplasms, neoplasms, storage-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Glycogen Storage Disease Type Viii, and have been seen in publications frequently: Cell Proliferation, Glucagon Secretion, Gluconeogenesis, Glycolysis, Intracellular Signal Transduction, Localization, Pathogenesis, Secretion, Transport

Quite a number of genes have been found to play important roles in Glycogen Storage Disease Type Viii, such as ARHGAP4, C2, FAH, G6PC, GCG, HNF1A, HNF4A, HNRNPC, INS, INSR, IRS1, PFDN4, PHKA1, PHKA2, POMC, PYGM, SLC2A2, SLC37A4. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Glycogen Storage Disease Type Viii Related Genes

click to see detail information for each gene

Pathways Related to Glycogen Storage Disease Type Viii

This information is being compiled and will come in a future update

Related Diseases